DekaBank Deutsche Girozentrale’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,300
| Closed | -$434K | – | 1544 |
|
|
2023
Q2 | $434K | Hold |
11,300
| – | – | ﹤0.01% | 1050 |
|
|
2023
Q1 | $258K | Hold |
11,300
| – | – | ﹤0.01% | 1146 |
|
|
2022
Q4 | $289K | Hold |
11,300
| – | – | ﹤0.01% | 1159 |
|
|
2022
Q3 | $216K | Hold |
11,300
| – | – | ﹤0.01% | 1214 |
|
|
2022
Q2 | $200K | Hold |
11,300
| – | – | ﹤0.01% | 1186 |
|
|
2022
Q1 | $186K | Buy |
11,300
+1,000
| +10% | +$13.6K | ﹤0.01% | 1221 |
|
|
2021
Q4 | $162K | Buy |
10,300
+300
| +3% | +$4.27K | ﹤0.01% | 1298 |
|
|
2021
Q3 | $124K | Hold |
10,000
| – | – | ﹤0.01% | 1280 |
|
|
2021
Q2 | $140K | Hold |
10,000
| – | – | ﹤0.01% | 1287 |
|
|
2021
Q1 | $162K | Hold |
10,000
| – | – | ﹤0.01% | 1223 |
|
|
2020
Q4 | $159K | Buy |
+10,000
| New | +$151K | ﹤0.01% | 1211 |
|
|
2019
Q3 | – | Sell |
-11,680
| Closed | -$102K | – | 1152 |
|
|
2019
Q2 | $102K | Buy |
11,680
+4,540
| +64% | +$69.1K | ﹤0.01% | 1082 |
|
|
2019
Q1 | $241K | Buy |
7,140
+1,300
| +22% | +$22.7K | ﹤0.01% | 1017 |
|
|
2018
Q4 | $75K | Sell |
5,840
-1,300
| -18% | -$26K | ﹤0.01% | 1103 |
|
|
2018
Q3 | $241K | Hold |
7,140
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q2 | $253K | Hold |
7,140
| – | – | ﹤0.01% | 1014 |
|
|
2018
Q1 | $327K | Sell |
7,140
-100
| -1% | -$3.66K | ﹤0.01% | 935 |
|
|
2017
Q4 | $409K | Hold |
7,240
| – | – | ﹤0.01% | 859 |
|
|
2017
Q3 | $409K | Hold |
7,240
| – | – | ﹤0.01% | 865 |
|
|
2017
Q2 | $414K | Buy |
+7,240
| New | +$363K | ﹤0.01% | 862 |
|
|
2016
Q3 | – | Sell |
-7,240
| Closed | -$397K | – | 1042 |
|
|
2016
Q2 | $397K | Buy |
7,240
+780
| +12% | +$47.4K | ﹤0.01% | 715 |
|
|
2016
Q1 | $391K | Buy |
+6,460
| New | +$523K | ﹤0.01% | 700 |
|
DekaBank Deutsche Girozentrale's KDNY Position: Q3 2023 in Review
DekaBank Deutsche Girozentrale sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 11,300 shares — an estimated $434K sold.
DekaBank Deutsche Girozentrale first reported a position in KDNY in Q1 2016 and held it in 22 quarters. The position peaked at $434K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- DekaBank Deutsche Girozentrale reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 11,300 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $434K.
- DekaBank Deutsche Girozentrale first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2016 and held it in 22 quarters.
- DekaBank Deutsche Girozentrale's Chinook Therapeutics, Inc. Common Stock position peaked at $434K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2023, filed 13 Nov 2023.